6th International Young Scientist Congress (IYSC-2020) and Workshop on Intellectual Property Rights. 10th International Science Congress (ISC-2020).  International E-publication: Publish Projects, Dissertation, Theses, Books, Souvenir, Conference Proceeding with ISBN.  International E-Bulletin: Information/News regarding: Academics and Research

Hepatoprotective Activity of Kadukkai Maathirai (A Siddha Polyherbal Formulation) Against Carbon Tetrachloride Induced Liver Damage in Rat

Author Affiliations

  • 1 National Institute of Siddha, Chennai, INDIA
  • 2 Departments of Pharmacology, Melaka Manipal Medical College, Manipal University, INDIA
  • 3 Captain Sriniwasa Murthy Research Institute for Ayurveda and Siddha Drug Development, Chennai, INDIA

Res. J. of Pharmaceutical Sci., Volume 1, Issue (4), Pages 17-21, December,30 (2012)


Kadukkai maathirai (KM) is a polyherbal formulation used in traditional Siddha Medicine for the treatment of liver diseases and iron deficiency anemia. This study was aimed to create preclinical scientific evidence on hepatoprotective activity of KM. Five groups, with six rats in each group were used in this study. Group 1 (normal rats) did not receive any drug. Group 2, 3, 4 and 5 received carbon tetrachloride (CCl4) 1mg/kg twice a week (on third day and seventh days of each week) for four weeks to induce hepatic damage. Group 2 (vehicle control) received only vehicle. Group 3 and group 4 were treated with two doses of KM, 36mg/kg and 72mg/kg respectively for 28 days. Group 5 (standard) received silymarin 25mg/Kg for 28 days. On 29th day, blood was collected for estimation of aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP)and total bilirubin (TB). Liver was collected for histopathological examination. Group 2 showed significant (P < 0.001) increase in levels of AST, ALT, ALP and TB compared to group 1 indicating the liver damage caused by CCl4. KM treated Group 3 and group 4 showed a dose dependent reduction of all enzyme levels. Group 3 and group 4 showed significant (P < 0.001) reduction in AST, ALT, ALP and TB levels when compared to vehicle control indicate the recovery of hepatic cells. Histology examination revealed that KM treatment reduced the hepatocellular necrosis in a dose dependent manner. Our study demonstrated the dose dependent hepatoprotective activity of KM against CCl4 induced liver injury. However, future study will be directed on molecular mechanism of individual ingredients, toxicity profile and clinical studies in various liver diseases.


  1. Traditional medicine growing needs and potential, WHO Policy Perspectives on Medicine, No.002. Geneva: World Health Organization (2002)
  2. Payyappallimana U., Role of Traditional Medicine in primary health care: An overview of perspectives and challenges, Yokohama Journal of Social Sciences, 14(6),723-743 (2010)
  3. Velayudam., Ilavarasan., Amuthan A., Physico-chemical evaluation of Kadukkai maathirai and its tablet formulation, a Siddha iron preparation used in anemia, Int J Pharmacol and Clin Sci, 1(1), 3-8 (2012)
  4. Narayanaswamy V., Pharmacopoeia of Hospital of Indian Medicine, India: Tamilnaud Siddha Medical Board, 34, (1995)
  5. Acute oral toxic class method guideline 423 adopted 23.03.1996, In: Eleventh Addendum to the, OECD, guidelines for the testing of chemicals organisation for economical co-operation and development. Paris (2000)
  6. Yacout G.A., Elguindy N.M., El Azab E.F., Amelioratic effect of Zingiber officinale on experimentally induced liver fibrosis in rats, Journal of Medical Research Institute,28(2), 154-159 (2007)
  7. King J., The hydrolases–acid and alkaline phosphates, In: Practical clinical enzymology, London: D Van Nostrand Company, 191-208 (1965)
  8. Malloy H.T., Evelyn K.A., The determination of bilirubin with the photometric colorimeter, J Biol Chem, 119, 481-490 (1937)
  9. Recknagel R.O., Carbon tetrachloride hepatotoxicity: status quo and future prospects, Trends Pharmacol Sci, , 129-131 (1983)
  10. James G.W. and Pickering R.W., The protective effect of a novel compound RU 18492, on galactosamine-induced hepatotoxicity in the rat, Drug Research, 26, 2179-2180 (1976)
  11. Burke M.D., Liver function: test selection and interpretation of results, Clin Lab Med, 22(2), 377-90 (2002)
  12. Thabrew M.I., Joice P.D. and Rajatissa W., A comparative study of the efficacy of Pavetta indica and Osbeckia octandra in the treatment of liver dysfunction, Planta Medica, 53(3), 239-241 (1987)
  13. Karwani G. and Sisodia S.S., Hepatoprotective activity of Mimosa pudica Linn. in carbon tetrachloride induced hepatotoxicity in rats, Journal of Herbal Medicine and Toxicology; 5(1), 27-32 (2011)
  14. Tasduq S.A., Singh K., Satti N.K., Gupta D.K., Suri K.A. and Johri R.K., Terminalia chebula (fruit) prevents liver toxicity causes by sub-chronic administration of rifampicin, isoniazid and pyrazinamide in combination, Hum Exp Toxicol, 25,(3) 111-118 (2006)
  15. Nirwane A.M. and Bapat A.R., Effect of methanolic extract of Piper nigrum fruit in ethanhol-CCl4 induced hepatotoxicity in Wistar rats, Der Pharmacia Lettre, 4(3), 795-802 (2012)
  16. Bai X., Zhang W., Chen W., Zong W., Guo Z. and Liu X., Anti-hepatotoxic and antioxidant effects of extracts from Piper nigrum L. root, African Journal of Biotechnology, 10(2), 267-272 (2011)
  17. Saxena A.K., Singh B. and Anand K.K., Hepatoprotective effects of Eclipta alba on subcellular levels in rats, J Ethnopharmacol, 40(3), 156-161 (1993)
  18. Thirumalai T., David E., Therasa S.V. and Elumalai E.K., Restorative effect of Eclipta alba in CCl4 induced hepatotoxicity in male albino rats, Asian Pacific Journal of Tropical Disease, 1(4), 304-307 (2011)
  19. Baranisrinivasan P., Elumalai E.K., Siakumar C., Therasa S.V. and David E., Hepatoprotective effect of Enicostemma littorale blume and Eclipta alba during ethanol induced oxidative stress in albino rats, International Journal of Pharmacology,5(4), 268-272 (2009)
  20. Tabassum N. and Agarwal S.S, Hepatoprotective activity of Eclipta alba Hassk. against paracetamol induced hepatocellular damage in mice, JK-Practic, 11(4), 278-280 (2004)
  21. Bhavsar S.K., Joshi P., Shah M.B. and Santani D.D., Investigation into hepatoprotective activity of Citrus limon,Pharmaceutical Biology, 45(4), 303-311 (2007)
  22. Casas R.G., Jones E.A. and Otero R.M., Spectrum of anemia associated with chronic liver disease, World J Gastroenterol, 15(37), 4653-4658 (2009)
  23. DeMaeyer E.M., Preventing and controlling iron deficiency anaemia through primary health care: A guide for health administrators and programme managers, Geneva: World health Organization, 17 (1990)
  24. Hyder S.M.Z., Persson L.A., Chowdhury A.M.R. and Ekstrom E.C., Do side-effects reduce compliance to iron supplementation? A study on daily and weekly dose regimens in pregnancy, J Health Popul Nutr, 20(2), 175-179 (2002)
  25. Tamhane M.D., Thorat S.P., Rege N.N. and Dahanukar S.A., Effect of oral administration of Terminalia chebulaon gastric emptying: an experimental study, J Postgrad Med, 43(1), 12-13 (1997)
  26. Mukherjee P.K., Rai S., Bhattacharya S., Bebnath P.K., Biswas T.K. and Jana U., et al, Clinical study of Triphala – a well-known phytomedicine from India, Iran J Pharmacol Therapeut, 5(1), 51-54 (2006)